Kidney Disease (Pediatric) Clinical Trials

A listing of Kidney Disease (Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 254 clinical trials
featured
Standardized Care to Improve Outcomes in Pediatric ESRD (SCOPE): A National Quality Improvement Initiative

This project is being offered to pediatric nephrology centers that seek to improve the health care of children by reducing exit site infection and peritonitis rates.  This project will also serve as starting point for building collegial network of pediatric nephrology centers skilled in successful quality improvement efforts that in …

  • 18 views
  • 11 Jun, 2020
  • 1 location
featured
An Open-Label, Randomized, Parallel Group Study to Assess the Safety and Efficacy of Hectorol® (doxercalciferol capsules) in Pediatric Patients with Chronic Kidney Disease Stages 3 and 4 with Secondary Hyperparathyroidism Not Yet on Dialysis

This is a randomized, open label, parallel, active comparator study in patients aged 5– 18 years with Chronic Kidney Disease (CKD) Stages 3 and 4 and secondary hyperparathyroidism (SHPT) not yet on dialysis. The study aims to evaluate the effect of Hectorol® capsules in reducing elevated levels of intact parathyroid …

  • 45 views
  • 11 Jun, 2020
  • 1 location
featured
The Nephrotic Syndrome Study Network (NEPTUNE)

NEPTUNE consists of two longitudinal observational cohort studies. One of which is following patients with biopsy proven FSGS, MCD or MN (cohort A). The other longitudinal observational cohort study is on children who were recently diagnosed with nephrotic syndrome (cohort B). There are no drugs or devices involved in this …

  • 45 views
  • 11 Jun, 2020
  • 1 location
featured
CureGN: Cure Glomerulonephropathy Network

CureGN is a prospective longitudinal study following patients with glomerular disease  

  • 34 views
  • 11 Jun, 2020
  • 1 location
featured
AREN03B2: Study of Kidney Tumors in Young Patients

AREN03B2: Study of Kidney Tumors in Young Patients

  • 36 views
  • 08 Nov, 2020
  • 1 location
Ultrasonic vs. Fluoroscopic Guided PNL in Pediatric Renal Stones

Percutaneous Nephrolithotomy (PNL) was accepted as a treatment modality for large renal stones since 1980. Although radiation exposure during PNL is within the safe limits for expert endourologist, the mutagenic hazard is still present especially in pediatric population. Therefore, employing an alternative imaging technique during PNL would be of added …

  • 3 views
  • 01 Aug, 2021
  • 1 location
A Phase 2b Diabetic Kidney Disease Study

A Phase 2b Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of MEDI3506 in Subjects with Diabetic Kidney Disease

nephropathy
diabetic nephropathy
  • 54 views
  • 17 Jul, 2021
  • 116 locations
A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney Disease

This study is open to adults with diabetic kidney disease. The purpose of the study is to find out whether a medicine called BI 685509 improves kidney function. Three different doses of BI 685509 are tested in this study. Participants get either one of the three doses of BI 685509 …

microalbumin/creatinine ratio
antihypertensive drugs
glucagon
albumin/creatinine ratio
glomerular filtration rate
  • 0 views
  • 01 Aug, 2021
  • 36 locations
Pentoxifylline in Diabetic Kidney Disease

Pentoxifylline (PTX) is a medication that has been on the market since 1984 for use in disease in the blood vessels of the legs. There is some preliminary information that it may protect the kidneys from damage due to diabetes and other diseases. "Pentoxifylline in Diabetic Kidney Disease" is a …

pentoxifylline
nephropathy
diabetic nephropathy
diabetes
  • 6 views
  • 16 Mar, 2021
  • 6 locations
Safety Tolerability and Efficacy of Nidufexor in Patients With Diabetic Nephropathy

Nidufexor addresses fibrosis, oxidative stress, inflammation and cell death, and therefore has the potential to improve the management of diabetic kidney disease when added to the standard of care (angiotensin converting enzyme inhibitor or angiotensin receptor blocker). This non-confirmatory Phase 2 study is designed to determine the safety, tolerability, efficacy, …

enzyme inhibitors
ace inhibitor
diabetes
nephropathy
angiotensin
  • 66 views
  • 25 Apr, 2021
  • 23 locations